![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
|
Contact: Gina Kirchweger
gxk@stowers.org
816-806-1036
Stowers Institute for Medical Research
Caption: When PARP1 and NAD+ are on the scene, they alter the state of the chromatin-remodeling enzyme and suspected oncogene ALC1 from dormant to active.
Credit: Courtesy of Rushi Trivedi, Stowers Institute for Medical Research
Usage Restrictions: None
Related news release: Activating ALC1: With a little help from friends
|